Pulse Biosciences CS (PLSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -72,781 | -55,348 | -35,963 | -16,795 | -53,585 |
| Depreciation Amortization | 1,071 | 812 | 556 | 283 | 1,178 |
| Accounts receivable | -274 | -15 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,132 | 1,318 | 1,044 | 712 | -201 |
| Other Working Capital | -5,022 | -2,165 | -1,791 | -2,690 | 1,549 |
| Other Operating Activity | 21,752 | 16,031 | 9,826 | 4,969 | 14,716 |
| Operating Cash Flow | $-54,122 | $-39,367 | $-26,328 | $-13,521 | $-36,343 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -315 | -210 | -148 | -45 | -125 |
| Purchase Sale Intangibles | -20 | -20 | -20 | N/A | N/A |
| Other Investing Activity | -20 | -20 | -20 | 0 | 0 |
| Investing Cash Flow | $-335 | $-230 | $-168 | $-45 | $-125 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 17,154 | 16,773 | 14,807 | 14,807 | 110,422 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -281 |
| Financing Cash Flow | $17,154 | $16,773 | $14,807 | $14,807 | $110,141 |
| Beginning Cash Position | 118,038 | 118,038 | 118,038 | 118,038 | 44,365 |
| End Cash Position | 80,735 | 95,214 | 106,349 | 119,279 | 118,038 |
| Net Cash Flow | $-37,303 | $-22,824 | $-11,689 | $1,241 | $73,673 |
| Free Cash Flow | |||||
| Operating Cash Flow | -54,122 | -39,367 | -26,328 | -13,521 | -36,343 |
| Capital Expenditure | -315 | -210 | -148 | -45 | -125 |
| Free Cash Flow | -54,437 | -39,577 | -26,476 | -13,566 | -36,468 |